Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
Gilead has announced that lenacapavir, the game-changing HIV prevention drug just approved by the FDA will cost $28,218 USD per person per year.
Researchers say a generic version could be made for just $25 per person a year.
Capitalism kills.
@luckytran I van imagine that 28k is not realistic but neither is 25$
I suppose a moral calculation for cost per unit would look something like this:
1) production cost
2) cost based licence/development costs (including overhead) decided by the number of expected sales (potential number of patients times duration of licencing rights
3) morally acceptable profit margin
No idea what these numbers would come out to but this would be how to derive them.